MOVING AHEAD REQUIRES A SURE PATH FORWARD
Trials are inherently risky, and every detail matters. We spot risks before they become problems to help you avoid costly delays through an array of solutions that provide confidence at every turn.
ENHANCE TRIAL OVERSIGHT
Run more efficient trials by unlocking hidden insights
enable site optimization
Generate high-quality data by optimizing site selection and performance
increase patient engagement
Equip patients with the tools to take control of their health
ensure safety and measure efficacy
By driving high-quality data
THE ERT EXPERT PLATFORM
The ERT EXPERT® platform is the underlying proprietary technology that powers all ERT solutions. Improve trial visibility and performance and reduce time-to-market with confidence, agility and acceleration.
MINIMIZe RISK AND UNCERTAINTY
We enable the flexibility and adaptability you need to accelerate through hurdles for faster speed to market. Here’s how:
Every trial runs into unexpected challenges. With more than 13,000 trials under our belt, we’ve seen most of them before and have the expertise to put your trial back on course.
We’ll protect the success of your trial before there’s ever an issue, with near real-time access to study, program and enterprise-level performance.
NEWS & EVENTS
May 22 - 23, 2018
Outsourcing in Clinical Trials East Coast 2018
Join Drew Bustos, ERT’s head of Product Management, Trial Oversight, as he presents “Beyond Risk-based Monitoring: Employing Risk-based Management” at noon May 22.
May 18, 2018
How to Improve Patient Outcomes with Digital Health
This article presents the factors that are critical in designing effective patient support solutions and reviews learnings from a recent workshop that demonstrate the importance of understanding, recognizing and solving real problems in order to truly impact health outcomes.
April 26, 2018
Debunking the Myths about eCOA in Clinical Trials
This article demystifies some of the common myths about using eCOA in clinical trials, and presents the core advantages to all clinical trial sponsors & CROs, regardless of their size.